JANX

JANUX THERAPEUTICS INC

JANX·47103J105·US·Common Stock·Healthcare - Biotechnology-13D/G

JANX (JANUX THERAPEUTICS INC) is held by 109 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($171.9M), BlackRock, Inc. ($94.2M), STATE STREET CORP ($46.2M). Net institutional sentiment: Mixed.

109
Holders
(6 Elite)
$749.8M
Total Value
62% (109)
Consensus
68 buying - 41 selling
13F: Insider & Congress: Updated regularly
JANX

Smart Money Verdict

View all
Loading verdict
Held by 109 funds
6 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 12, 2026 · Activists Aug 14, 2026 · Congress none

ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.3.3%Aug 14, 2026
ActivistJANUS HENDERSON GROUP Ltd.JANUS HENDERSON GROUP Ltd.0.3%Aug 13, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.7%Jul 28, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
11.2M$171.9M1.5%-32.24%
0
Increased
6.1M(+12.9%)$94.2M0.0%-42.41%
34
Increased
3M(+21.9%)$46.2M0.0%-9.94%
35
Decreased
2.4M(-4.8%)$37.1M0.0%-63.25%
0
Increased
2.4M(+4241.2%)$36.1M0.1%+23.32%
47
Increased
2M(+72.5%)$30.6M0.0%-10.05%
43
Increased
1.9M(+2.5%)$28.5M0.0%+40.06%
29
Increased
1.6M(+2.9%)$25.3M0.1%+10.33%
29
Decreased
1.5M(-5.7%)$23.2M0.0%-24.57%
0
Increased
1.3M(+3.1%)$20.4M0.0%+39.94%
29
Increased
1.2M(+939.9%)$18.5M0.0%+22.58%
46
Increased
1.2M(+5.0%)$18.5M0.0%-27.97%
30
Increased
1.2M(+240.9%)$18.4M0.0%+8.58%
46
Increased
1.1M(+1014.4%)$16.8M0.0%+24.28%
46
Increased
952,675(+58.3%)$14.6M0.0%-17.98%
40
Increased
910,460(+13.6%)$14M0.0%-42.59%
32
Increased
836,966(+18.9%)$12.9M0.0%-28.16%
33
Increased
702,057(+256.1%)$10.8M0.0%-4.02%
45
Decreased
532,321(-11.9%)$8.2M0.0%+25.27%
0
Increased
504,544(+30.4%)$7.7M0.0%+3.69%
35

Showing 1-20 of 120

1 / 6
JANXJANXJANUX THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used